Drug utilization of oral hypoglycemic agents in a university teaching hospital in IndiaSULTANA, G; KAPUR, P; AQIL, M et al.Journal of clinical pharmacy and therapeutics (Print). 2010, Vol 35, Num 3, pp 267-277, issn 0269-4727, 11 p.Article

Depression in patients with type 2 diabetes : Impact on adherence to oral hypoglycemic agentsKALSEKAR, Iftekhar D; MADHAVAN, Suresh S; AMONKAR, Mayur M et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 4, pp 605-611, issn 1060-0280, 7 p.Article

Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysisVANDERPOEL, Daniel R; HUSSEIN, Mohamed A; WATSON-HEIDARI, Teresa et al.Clinical therapeutics. 2004, Vol 26, Num 12, pp 2066-2075, issn 0149-2918, 10 p.Article

Ipragliflozin and other sodium―glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: Preclinical and clinical dataKUROSAKI, Eiji; OGASAWARA, Hideaki.Pharmacology & therapeutics (Oxford). 2013, Vol 139, Num 1, pp 51-59, issn 0163-7258, 9 p.Article

Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus : A retrospective cohort analysisKALSEKAR, Iftekhar D; MADHAVAN, Suresh S; AMONKAR, Mayur M et al.Clinical therapeutics. 2006, Vol 28, Num 2, pp 306-318, issn 0149-2918, 13 p.Article

Perinatal outcomes and the use of oral hypoglycemic agentsBERTINI, Anna Maria; SILVA, Jean Carl; TABORDA, Wladimir et al.Journal of perinatal medicine. 2005, Vol 33, Num 6, pp 519-523, issn 0300-5577, 5 p.Article

Childhood obesity and type 2 diabetes mellitusHANNON, Tamara S; RAO, Goutham; ARSLANIAN, Silva A et al.Pediatrics (Evanston). 2005, Vol 116, Num 2, pp 473-480, issn 0031-4005, 8 p., 1Article

Type 2 Diabetes and Oral Antihyperglycemic DrugsMIZUNO, Cassia S; CHITTIBOYINA, Amar G; KURTZ, Theodore W et al.Current medicinal chemistry. 2008, Vol 15, Num 1, pp 61-74, issn 0929-8673, 14 p.Article

Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter StudySOLINI, Anna; PENNO, Giuseppe; FERRANNINI, Ele et al.Journal of the American Geriatrics Society. 2013, Vol 61, Num 8, pp 1253-1261, issn 0002-8614, 9 p.Article

The Nephroprotective Effects of Pioglitazone and Glibenclamide Against Gentamicin-Induced Nephrotoxicity in Rats: A Comparative StudyAL-AZZAM, S. I; ABDUL-RAZZAK, K. K; JARADAT, M. W et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 88-91, issn 1120-009X, 4 p.Article

Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes MellitusJIN AH JUNG; KAKU, Kohei; JAE HYEON KIM et al.Advances in therapy. 2013, Vol 30, Num 11, pp 1018-1029, issn 0741-238X, 12 p.Article

Predictors of Medication Nonadherence Among Patients With Diabetes in Medicare Part D Programs: A Retrospective Cohort StudyYI YANG; THUMULA, Vennela; PACE, Patrick F et al.Clinical therapeutics. 2009, Vol 31, Num 10, pp 2178-2188, issn 0149-2918, 11 p.Article

Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in ratsIWASE, Masanori; NAKAMURA, Udai; UCHIZONO, Yuji et al.European journal of pharmacology. 2005, Vol 518, Num 2-3, pp 243-250, issn 0014-2999, 8 p.Article

Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of Type 2 diabetic model ratsHANNAN, J. M. A; ROKEYA, B; FARUQUE, O et al.Journal of ethnopharmacology. 2003, Vol 88, Num 1, pp 73-77, issn 0378-8741, 5 p.Article

Long-term therapeutic effects of voglibose, a potent intestinal alpha-glucosidase inhibitor, in spontaneous diabetic GK ratsYASUDA, K; SHIMOWADA, K; TSUDA, K et al.Diabetes research and clinical practice. 2003, Vol 59, Num 2, pp 113-122, issn 0168-8227, 10 p.Article